HemaCare Corp. (HEMA)


Other OTC - Other OTC Delayed Price. Currency in USD
0.630.00 (0.00%)
At close: 12:28 PM EDT
People also watch:
HMGNCVASLCARCNCTEMIS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close0.63
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market Cap6.77M
P/E Ratio (ttm)2.09
Beta1.15
Volume0
Avg Vol (3m)1,540
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire20 hours ago

    HemaCare Supports 2016 CAR-TCR Summit

    HemaCare Corporation , a leader in cell and tissue collection, processing, and cell therapy solutions, today announced that it is supporting the 2016 CAR-TCR Summit to be hosted at the Hyatt Regency in Boston September 13-15th.

  • Business Wire2 months ago

    HemaCare Achieves Q2 Conference Goals

    HemaCare Corporation, a leader in cell and tissue collection, processing, and cell therapy solutions, today announced that it achieved its Q2 marketing goals of driving greater awareness of its capabilities to potential new customers, as well as maintaining and developing deeper collaborations with current customers and partners.

  • Business Wire3 months ago

    HemaCare Attends BIO 2016 and Stem Cell Research Meetings

    HemaCare Corporation, a leader in cell and tissue collection, processing and cell therapy solutions, today announced that it will be attending two key conferences during the month of June in San Francisco.